Avoid common mistakes on your manuscript.
Correction: Gastric Cancer (2020) 23:988–1002 https://doi.org/10.1007/s10120-020-01088-y.
In Fig. 4a and 5a of this article, the representative western blot images of mTOR (in Fig. 4a) and β-actin of BGC-823 cells (in Fig. 5a) were mistakenly inserted; the Fig. 4a and 5a should have appeared as shown below.
Fig. 4a MGC-803 and BGC-823 cells, as well as resistant cells, were treated with 1 μM AZD4547 for 24 h and immunoblotted with LC3, p62, p-AMPK, total AMPK, p-mTOR, total mTOR, p-S6, total S6, and GAPDH.
Fig. 5a BGC-823 and BGC-823R and MGC-803 and MGC-803R cells were untreated or treated with 1 μM AZD4547 for 24 h. Protein levels of p-ERK, ERK, and β-actin were measured by western blot assays.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Peng, R., Chen, Y., Wei, L. et al. Correction: Resistance to FGFR1-targeted therapy leads to autophagy via TAK1/AMPK activation in gastric cancer. Gastric Cancer 27, 643–645 (2024). https://doi.org/10.1007/s10120-024-01489-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10120-024-01489-3